CX NEWS
IPD meta-analysis to show “highest level of evidence” for EVAR vs. open repair
Principal investigators: Roger Greenhalgh, Jan Blankensteijn, Jean-Pierre Becquemin and Frank Lederle. An Individual Patient Data (IPD) meta-analysis of the randomised controlled trials—EVAR 1, DREAM, ACE and OVER—will show the “highest level of evidence” [...]
Longest follow-up for EVAR to be presented for the first time at CX 2016
Roger Greenhalgh. Fifteen-year follow-up of the Endovascular Aneurysm Repair (EVAR) 1 Trial will be presented for the first time at CX 2016. The EVAR 1 Trial was the first EVAR vs. open repair [...]
Interview with Michel Makaroun at CX 2015
Interview with Michel Makaroun at CX 2015
Interview with Ian Franklin at CX 2015: New venous technologies
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been [...]
Interview with Janet Powell at CX 2015: IMPROVE trial 12-month results
Janet Powell, Imperial College, London, UK, is interviewed about the 12-month results of the IMPROVE trial, presented for the first time at CX 2015. The study compares open repair and an endovascular strategy for ruptured abdominal aortic aneurysms.